Study reveals survival benefit for CTCL patients treated with mogamulizumab
22nd October 2025 Uncategorised 0
International registry highlights impact of POTELIGEO in rare lymphoma subtypes

More: Study reveals survival benefit for CTCL patients treated with mogamulizumab
Source: News
